Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/50820
Campo DC Valoridioma
dc.contributor.authorMorales, Victoriaen_US
dc.contributor.authorGonzalez Robayna, I.en_US
dc.contributor.authorSantana, M. Pinoen_US
dc.contributor.authorHernandez, Inmaculadaen_US
dc.contributor.authorFanjul Rodríguez, Luisa Fernandaen_US
dc.contributor.otherGonzalez Robayna, Ignacio-
dc.contributor.otherHernandez Gonzalez, Inmaculada-
dc.date.accessioned2018-11-24T19:07:31Z-
dc.date.available2018-11-24T19:07:31Z-
dc.date.issued2006en_US
dc.identifier.issn0013-7227en_US
dc.identifier.urihttp://hdl.handle.net/10553/50820-
dc.description.abstractThe proinflammatory cytokine TNFα has important actions at the level of the ovary, including inhibition of P450 aromatase (P450AROM) activity and the secretion of inhibin, two proteins that are markers of the granulosa cell's differentiated status. Because the transcription of both P450AROM and inhibin α-subunit can be suppressed in the ovary by the inducible repressor isoform of cAMP-responsive element binding modulator (ICER), we have investigated whether TNFα and its intracellular messenger ceramide can induce ICER expression and the mechanisms whereby the induction is accomplished. ICER mRNA levels were assessed by RT-PCR in granulosa cells treated with TNFα, the ceramide-mobilizing enzyme sphingomyelinase (SMase), or C6-cer, a cell-permeant ceramide analog. Rapid (3 h) yet transient increases in the four isoforms of ICER were observed in response to all treatments. Likewise, ICER protein measured by immunoprecipitation with a specific antibody increases after TNFα, SMase, or C6-cer treatment. The mandatory phosphorylation of cAMP-responsive element binding was also observed in response to TNFα, SMase, or C6-cer and shown to be prevented by the p44/42 MAPK-specific inhibitor PD098059 but no other kinase blockers. Activation of p44/42 MAPK by the cytokine and its messenger was subsequently demonstrated as well as the inhibition of ICER expression by PD098059. Finally, the blocking of p44/42 MAPK activation prevented TNFα inhibition of FSH-dependent increases in P450AROM and inhibin α-subunit mRNA levels, thus indicating that p44/42 MAPK-mediated ICER expression may be accountable for the effects of TNFα on the expression of both proteins.en_US
dc.languageengen_US
dc.relation.ispartofEndocrinology (Philadelphia)en_US
dc.sourceEndocrinology, [ISSN 0013-7227], v. 147 (12), p. 5932-5939en_US
dc.subject320101 Oncologíaen_US
dc.subject.otherCamp Early Repressoren_US
dc.subject.otherMessenger-Ribonucleic-Aciden_US
dc.subject.otherLong-Term Desensitizationen_US
dc.subject.otherColony-Stimulating Factoren_US
dc.subject.otherTnf Receptor Superfamilyen_US
dc.subject.otherNuclear Factor Creben_US
dc.subject.otherGene-Expressionen_US
dc.subject.otherIn-Vitroen_US
dc.subject.otherCyclic Adenosine-3',5'-Monophosphateen_US
dc.subject.otherCytochrome-P450 Aromataseen_US
dc.titleTumor necrosis factor-α activates transcription of inducible repressor form of 3′,5′-cyclic adenosine 5′-monophosphate- responsive element binding modulator and represses P450 aromatase and inhibin α-subunit expression in rat ovarian granulosa cells by a p44/42 mitogen-activated protein kinase-dependent mechanismen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1210/en.2006-0635en_US
dc.identifier.pmid16946004-
dc.identifier.scopus33751506107-
dc.identifier.isi000242047200048-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dcterms.isPartOfEndocrinology-
dcterms.sourceEndocrinology[ISSN 0013-7227],v. 147 (12), p. 5932-5939-
dc.contributor.authorscopusid7005232305-
dc.contributor.authorscopusid6507425244-
dc.contributor.authorscopusid57198378379-
dc.contributor.authorscopusid7102922509-
dc.contributor.authorscopusid57211220417-
dc.contributor.authorscopusid7004158812-
dc.description.lastpage5939en_US
dc.identifier.issue12-
dc.description.firstpage5932en_US
dc.relation.volume147en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000242047200048-
dc.contributor.daisngid1664025-
dc.contributor.daisngid2922182-
dc.contributor.daisngid22701702-
dc.contributor.daisngid2446020-
dc.contributor.daisngid1127140-
dc.description.observacionesThis work was supported by the Direccion General de Enseñanza Superior e Investigación Científica Grant 98/0234en_US
dc.identifier.investigatorRIDK-9671-2014-
dc.identifier.investigatorRIDK-7776-2014-
dc.description.numberofpages8en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Morales, V-
dc.contributor.wosstandardWOS:Gonzalez-Robayna, I-
dc.contributor.wosstandardWOS:Santana, MP-
dc.contributor.wosstandardWOS:Hernandez, I-
dc.contributor.wosstandardWOS:Fanjul, LF-
dc.date.coverdateDiciembre 2006en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr5,236-
dc.description.jcrqQ1-
dc.description.scieSCIE-
item.fulltextCon texto completo-
item.grantfulltextopen-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0002-7650-4454-
crisitem.author.orcid0009-0000-1982-055X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameGonzález Robayna, Ignacio Javier-
crisitem.author.fullNameFanjul Rodríguez, Luisa Fernanda-
Colección:Artículos
Adobe PDF (396,12 kB)
Vista resumida

Citas SCOPUSTM   

17
actualizado el 21-abr-2024

Citas de WEB OF SCIENCETM
Citations

15
actualizado el 25-feb-2024

Visitas

56
actualizado el 03-jun-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.